NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gene Solutions

Gene Solutions

Private
Ho Chi Minh CityHealthcare & Life Scienceshttps://genesolutions.vn/

Last Round

Private Equity

Nov 18, 2025

Total Funding Raised

$36M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Gene Solutions is a biotechnology company that offers a comprehensive portfolio of advanced genetic testing solutions by integrating Next-Generation Sequencing (NGS) and Artificial Intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Drug Discovery

Business Model

B2B2C

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

non-invasive prenatal testingNIPTmulti-cancer early detectionliquid biopsyminimal residual diseaseMRDnext-generation sequencingNGSctDNAgenetic testingclinical oncologyreproductive healthmedical AIprecision medicinecomprehensive genomic profilingCGPbiomarker discoverydrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gene Solutions Comps

Public and private peers based on sector, stage, and business model.

Gene Solutions comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gene Solutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityNov 18, 2025
StrategicJan 9, 2025
Series CApr 3, 2024
Series B ExtensionSep 20, 2023
Series BOct 5, 2021

Key People

Founding team and executive leadership

Keng Hsu

Chief Financial Officer

Executive Team

Gene Solutions Investors

Notable investors and investment history

Gene Solutions investors
InvestorRounds
Mekong CapitalSeries B Extension, Series B
August Global PartnersSeries C, Strategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors increased 144% to 10,000.

  • Nov 18, 2025

    Raised $50M in a Private Equity round.

Gene Solutions Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gene Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gene Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersHo Chi Minh City
Employee Range341
Year Founded2017
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.